stockrowArrowhead Pharmaceuticals, Inc. (ARWR) vs Corcept Therapeutics Incorporated (CORT)
- Arrowhead Pharmaceuticals, Inc. ARWR 58.23 +1.34%
- Corcept Therapeutics Incorporated CORT 73.00 +1.91%
Arrowhead Pharmaceuticals, Inc. and Corcept Therapeutics Incorporated are both Biotechnology companies. Arrowhead Pharmaceuticals, Inc. and Corcept Therapeutics Incorporated are of similar size ($8.1B and $7.8B). Arrowhead Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Corcept Therapeutics Incorporated trades at 47.5×. Corcept Therapeutics Incorporated grew revenue faster over the last twelve months: 30.0% against 16.1%. Corcept Therapeutics Incorporated has the higher net margin (16.5% vs −47.8%) and the higher return on invested capital (15.0% vs 0.00%). Across the 19 metrics below, Corcept Therapeutics Incorporated leads on 14 and Arrowhead Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | ARWR | CORT | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 98.54% | 65.16% |
| Operating margin | (33.82%) | 11.51% | 0.00% |
| Net margin | (47.79%) | 16.54% | 0.00% |
| Free cash flow margin | (11.22%) | 20.20% | 0.00% |
| Return on equity | (64.91%) | 21.74% | (50.12%) |
| Return on assets | (18.32%) | 17.16% | (45.60%) |
| Return on invested capital | 0.00% | 14.97% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack